目次

TABLE OF CONTENTS

1 EXECUTIVE SUMMARY
1.1 OVERVIEW
1.2 MARKET SYNOPSIS

2 MARKET INTRODUCTION
2.1 SCOPE OF THE STUDY
2.2 RESEARCH OBJECTIVE
2.3 LIST OF ASSUMPTIONS

3 RESEARCH METHODOLOGY
3.1 OVERVIEW
3.2 DATA MINING
3.3 SECONDARY RESEARCH
3.4 PRIMARY RESEARCH
3.4.1 PRIMARY INTERVIEWS AND INFORMATION GATHERING PROCESS
3.4.2 BREAKDOWN OF PRIMARY RESPONDENTS
3.5 FORECASTING TECHNIQUES
3.6 RESEARCH METHODOLOGY FOR MARKET SIZE ESTIMATION
3.6.1 BOTTOM-UP APPROACH
3.6.2 TOP-DOWN APPROACH
3.7 DATA TRIANGULATION
3.8 VALIDATION

4 MARKET DYNAMICS
4.1 OVERVIEW
4.2 DRIVERS
4.2.1 INCREASING PREVALENCE OF HYDROCEPHALUS & SUBSEQUENT RISE IN NUMBER OF SHUNTING PROCEDURES
4.2.2 GROWING GERIATRIC POPULATION
4.3 RESTRAINT
4.3.1 COMPLICATIONS RELATED TO CSF SHUNT SYSTEMS
4.4 OPPORTUNITY
4.4.1 ENTERING DEVELOPING MARKETS
4.5 COVID-19 IMPACT ANALYSIS

5 MARKET FACTOR ANALYSIS
5.1 VALUE CHAIN ANALYSIS
5.1.1 R&D AND DESIGNING
5.1.2 MANUFACTURING
5.1.3 DISTRIBUTION
5.1.4 MARKETING AND SALES
5.1.5 POST-SALES MONITORING
5.2 PORTER’S FIVE FORCES MODEL
5.2.1 THREAT OF NEW ENTRANTS
5.2.2 BARGAINING POWER OF SUPPLIERS
5.2.3 BARGAINING POWER OF BUYERS
5.2.4 THREAT OF SUBSTITUTES
5.2.5 INTENSITY OF RIVALRY

6 GLOBAL CEREBROSPINAL FLUID MANAGEMENT DEVICES MARKET, BY PRODUCT
6.1 OVERVIEW
6.2 SHUNTS
6.3 CRITICAL CARE PRODUCTS
6.4 DURAL SEALANTS
6.5 OTHERS

7 GLOBAL CEREBROSPINAL FLUID MANAGEMENT DEVICES MARKET, BY AGE GROUP
7.1 OVERVIEW
7.2 PEDIATRIC
7.3 ADULT
7.4 GERIATRIC

8 GLOBAL CEREBROSPINAL FLUID MANAGEMENT DEVICES MARKET, BY END USER
8.1 OVERVIEW
8.2 HOSPITALS
8.3 AMBULATORY SETTINGS
8.4 RESEARCH & ACADEMIC INSTITUTES

9 GLOBAL CEREBROSPINAL FLUID MANAGEMENT DEVICES MARKET, BY REGION
9.1 OVERVIEW
9.2 AMERICAS
9.2.1 NORTH AMERICA
9.2.1.1 US
9.2.1.2 CANADA
9.2.2 LATIN AMERICA
9.3 EUROPE
9.3.1 WESTERN EUROPE
9.3.1.1 GERMANY
9.3.1.2 FRANCE
9.3.1.3 REST OF WESTERN EUROPE
9.3.1.4 UK
9.3.1.5 ITALY
9.3.1.6 SPAIN
9.3.2 EASTERN EUROPE
9.4 ASIA-PACIFIC
9.4.1 CHINA
9.4.2 JAPAN
9.4.3 REST OF ASIA PACIFIC
9.4.4 INDIA
9.4.5 SOUTH KOREA
9.4.6 AUSTRALIA
9.5 MIDDLE EAST & AFRICA
9.5.1 MIDDLE EAST
9.5.2 AFRICA

10 COMPETITIVE LANDSCAPE
10.1 OVERVIEW
10.2 COMPETITIVE BENCHMARKING
10.3 MAJOR GROWTH STRATEGY IN THE GLOBAL CEREBROSPINAL FLUID MANAGEMENT DEVICES MARKET
10.4 THE LEADING PLAYERS IN TERMS OF NUMBER OF DEVELOPMENTS IN THE GLOBAL CEREBROSPINAL FLUID MANAGEMENT DEVICES MARKET
10.5 KEY DEVELOPMENT ANALYSIS
10.6 KEY DEVELOPMENTS & GROWTH STRATEGIES
10.6.1 ACQUISITION ACTIVITIES
10.6.2 EXPANSIONS
10.6.3 PRODUCT LAUNCHES
10.7 FINANCIAL MATRIX
10.7.1 SALES
10.7.2 R&D EXPENDITURE

11 COMPANY PROFILES
11.1 MEDTRONIC PLC
11.1.1 COMPANY OVERVIEW
11.1.2 FINANCIAL OVERVIEW
11.1.3 PRODUCTS/SERVICES OFFERED
11.1.4 KEY DEVELOPMENTS
11.1.5 SWOT ANALYSIS
11.1.6 KEY STRATEGIES
11.2 NATUS MEDICAL INCORPORATED
11.2.1 COMPANY OVERVIEW
11.2.2 FINANCIAL OVERVIEW
11.2.3 PRODUCTS/SERVICES OFFERED
11.2.4 KEY DEVELOPMENTS
11.2.5 SWOT ANALYSIS
11.2.6 KEY STRATEGIES
11.3 B. BRAUN MELSUNGEN AG
11.3.1 COMPANY OVERVIEW
11.3.2 FINANCIAL OVERVIEW
11.3.3 PRODUCTS/SERVICES OFFERED
11.3.4 KEY DEVELOPMENTS
11.3.5 SWOT ANALYSIS
11.3.6 KEY STRATEGIES
11.4 SOPHYSA
11.4.1 COMPANY OVERVIEW
11.4.2 FINANCIAL OVERVIEW
11.4.3 PRODUCTS/SERVICES OFFERED
11.4.4 KEY DEVELOPMENTS
11.4.5 SWOT ANALYSIS
11.4.6 KEY STRATEGIES
11.5 IRRAS AB
11.5.1 COMPANY OVERVIEW
11.5.2 FINANCIAL OVERVIEW
11.5.3 PRODUCTS/SERVICES OFFERED
11.5.4 KEY DEVELOPMENTS
11.5.5 SWOT ANALYSIS
11.5.6 KEY STRATEGIES
11.6 MÖLLER MEDICAL GMBH
11.6.1 COMPANY OVERVIEW
11.6.2 FINANCIAL OVERVIEW
11.6.3 PRODUCTS/SERVICES OFFERED
11.6.4 KEY DEVELOPMENTS
11.6.5 SWOT ANALYSIS
11.6.6 KEY STRATEGIES
11.7 ARGI GRUP
11.7.1 COMPANY OVERVIEW
11.7.2 FINANCIAL OVERVIEW
11.7.3 PRODUCTS/SERVICES OFFERED
11.7.4 KEY DEVELOPMENTS
11.7.5 SWOT ANALYSIS
11.7.6 KEY STRATEGIES
11.8 LONGEVITI
11.8.1 COMPANY OVERVIEW
11.8.2 FINANCIAL OVERVIEW
11.8.3 PRODUCTS/SERVICES OFFERED
11.8.4 KEY DEVELOPMENTS
11.8.5 SWOT ANALYSIS
11.8.6 KEY STRATEGIES
11.9 INTEGRA LIFESCIENCES CORPORATION
11.9.1 COMPANY OVERVIEW
11.9.2 FINANCIAL OVERVIEW
11.9.3 PRODUCTS/SERVICES OFFERED
11.9.4 KEY DEVELOPMENTS
11.9.5 SWOT ANALYSIS
11.9.6 KEY STRATEGIES
11.10 ANUNCIA
11.10.1 COMPANY OVERVIEW
11.10.2 FINANCIAL OVERVIEW
11.10.3 PRODUCTS/SERVICES OFFERED
11.10.4 KEY DEVELOPMENTS
11.10.5 SWOT ANALYSIS
11.10.6 KEY STRATEGIES

12 APPENDIX
12.1 REFERENCES
12.2 RELATED REPORTS